Skip to content
  • Sunday, 26 July 2026
  • 4:35 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • A novel ‘asthma-on-a-chip’ platform breathes new life into study of the condition, offering hope for future treatments.
Biotech & Genetic Research

A novel ‘asthma-on-a-chip’ platform breathes new life into study of the condition, offering hope for future treatments.

Jia Lissa Jun 26, 2026 0

Engineers at the University of Pennsylvania (PA, USA) have engineered a groundbreaking human lung-on-a-chip technology, capable of replicating the intricate…

Read More
Pharmaceutical R&D

NICE Recommends Nucala for Severe Asthma and COPD, Expanding Access to Advanced Biologic Therapy in the UK

Teuku Ryan May 29, 2026 0

In a significant development for respiratory healthcare in the United Kingdom, the National Institute for Health and Care Excellence (NICE)…

Read More
Sensory Basis of Speech Motor Learning and Memory: A New Paradigm in Human NeuroscienceTWiV 1292: Clinical update with Dr. Daniel GriffinTokyo Metropolitan University Researchers Resolve Long Standing Foam Drainage Mystery Through Bubble Dynamics StudyTraumatic brain injury and Alzheimer’s disease: Common neuroinflammatory pathologies and therapeutic potential
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ